Merck Animal Health Announces the Availability of Experimental Autogenous Vaccine for Avian Metapneumovirus Type B through Its Agreement with Cambridge Technologies
First vaccine approved and produced in the U.S. to treat this disease in poultry RAHWAY, N.J., August 26, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the USDA has approved the manufacturing […]